Challenges of Sepsis Diagnosis and a new approach using the host immune response, SeptiCyte®
Back to course
Video Transcription
Video Summary
Asset Subtitle
Sepsis, Procedures, 2020
Asset Caption

The Society of Critical Care Medicine's Critical Care Congress features internationally renowned faculty and content sessions highlighting the most up-to-date, evidence-based developments in critical care medicine. This is a presentation from the 2020 Critical Care Congress held February 16-19, 2020, in Orlando, Florida, USA.


This session showcases the new SeptiCyte® RAPID test running on the Idylla™ platform. Learn about SeptiCyte® RAPID, a host response test, with actionable results in approximately one hour, differentiating sepsis from systemic inflammatory response syndrome (SIRS) with high negative predictive value (NPV), thus expediting and improving patient management for critically ill patients being admitted to the ICU. Steven P. LaRosa, MD, will address the challenges of current sepsis diagnosis and a new alternative approach leveraging the host immune response while Russell R® Miller III, MD, will present highlights from the VENUS study, a clinical validation of SeptiCyte® LAB.

This is sponsored by Immunexpress.

Meta Tag
Content Type Presentation
Knowledge Area Sepsis
Knowledge Area Procedures
Knowledge Level Advanced
Learning Pathway Sepsis Resources
Membership Level Select
Membership Level Professional
Membership Level Associate
Tag Infection
Tag Systemic Inflammatory Response Syndrome SIRS
Year 2020
Keywords
sepsis
septicite lab
diagnosing sepsis
gene expression analysis
Venus study
turnaround time
Procedures
Infection
Systemic Inflammatory Response Syndrome SIRS
Presentation
Select
Professional
Associate
2020
Advanced
Sepsis Resources